1. Home
  2. ONON vs HOLX Comparison

ONON vs HOLX Comparison

Compare ONON & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo On Holding AG

ONON

On Holding AG

HOLD

Current Price

$35.60

Market Cap

12.0B

ML Signal

HOLD

Logo Hologic Inc.

HOLX

Hologic Inc.

HOLD

Current Price

$76.02

Market Cap

16.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONON
HOLX
Founded
2010
1985
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Medical Electronics
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.0B
16.9B
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
ONON
HOLX
Price
$35.60
$76.02
Analyst Decision
Strong Buy
Hold
Analyst Count
20
13
Target Price
$60.15
$77.89
AVG Volume (30 Days)
5.4M
33.2M
Earning Date
05-12-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.79
Revenue
N/A
$4,100,500,000.00
Revenue This Year
$19.58
$4.74
Revenue Next Year
$19.98
$5.03
P/E Ratio
$56.05
$96.23
Revenue Growth
N/A
1.74
52 Week Low
$31.41
$51.90
52 Week High
$61.29
$76.07

Technical Indicators

Market Signals
Indicator
ONON
HOLX
Relative Strength Index (RSI) 46.21 69.09
Support Level $34.38 $75.10
Resistance Level $37.89 N/A
Average True Range (ATR) 1.17 0.19
MACD 0.25 0.03
Stochastic Oscillator 51.90 95.19

Price Performance

Historical Comparison
ONON
HOLX

About ONON On Holding AG

Founded in Switzerland in 2010, sportswear firm On Holding generates 93% of its sales from athletic shoes. The brand is best known for its running shoes and its distinctive CloudTec soles. On also produces athletic apparel (6% of sales) and accessories (1%). The firm's merchandise is available in more than 80 countries and is sold through both wholesale (58% of sales) and company-owned channels (42%). In 2025, On generated 58% of its sales in North America, 25% in Europe, the Middle East, and Africa, and 17% in the Asia-Pacific region.

About HOLX Hologic Inc.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Share on Social Networks: